Join industry leaders Tim Clark and Pablo Caló as they discuss the evolution of the secondary market and share insights from their experiences.
In this episode, Tim and Pablo delve into Pablo’s career arc, detailing how he ventured into secondary transactions and founded Fairview Capital. They explore the transformations in the secondary market over their careers and highlight the essential elements of successful GP-led transactions.
Discover the nuances of managing potential friction with LPs and LPACs, especially regarding conflicts and expenses in GP-led deals. Tim and Pablo provide valuable advice on minimising investor franchise risk and optimising deal approval.
The conversation also explores the rise of single asset continuation vehicles, addressing the shift from traditional exit tools and the significance of secondary buyers contributing dry powder for future growth.
Tim and Pablo navigate the complexities of the secondary marketplace, discussing the impact of artificial intelligence, drivers behind LP-led sale transactions, and the emerging trends in regions like Asia Pacific and Latin America.
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
MedTech Across Borders – Recent Developments in Japan and the US
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
Global Perspectives on Health Data Offerings and Considerations for Innovators
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting
MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan
Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business
Essential Antitrust Asia #8: Hot topics in China antitrust
Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023
Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct
Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools
MedTech - A Conversation with Stacy Hostetler
Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money